Bioavailability of Aronia Berry Polyphenols
Optimizing the Bioavailability and Metabolism of Aronia Berry Polyphenols for Improving Gut Health
3 other identifiers
interventional
13
1 country
1
Brief Summary
The objective of this study is to conduct a randomized cross-over dietary intervention among healthy adults to compare the bioavailability and the fecal polyphenol metabolites of intervention foods made with whole aronia berry powder, aronia berry extract, phospholipid-polyphenol (PLP), and a low-polyphenol control. 10 participants will be enrolled and can expect to be on study for up to 28 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2022
CompletedFirst Posted
Study publicly available on registry
August 5, 2022
CompletedStudy Start
First participant enrolled
February 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2023
CompletedMarch 31, 2023
March 1, 2023
2 months
August 1, 2022
March 28, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
Urinary Polyphenol Catabolite Concentration
Targeted analysis of free urinary polyphenol metabolites will be performed by ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS).
sampled on day 6, 13, 20, and 27 (participant randomized to different interventions each visit)
Urinary Anthocyanin Concentration
C18 solid-phase extraction (SPE) clean-up methods will be used to isolate anthocyanins and non-anthocyanin low-molecular weight polyphenol metabolites.
sampled on day 6, 13, 20, and 27 (participant randomized to different interventions each visit)
Fecal Polyphenol Catabolite Concentration
C18 solid-phase extraction (SPE) clean-up methods will be used to isolate anthocyanins and non-anthocyanin low-molecular weight polyphenol metabolites.
sampled on day 6, 13, 20, and 27 (participant randomized to different interventions each visit)
Fecal Anthocyanin Concentration
C18 solid-phase extraction (SPE) clean-up methods will be used to isolate anthocyanins and non-anthocyanin low-molecular weight polyphenol metabolites.
sampled on day 6, 13, 20, and 27 (participant randomized to different interventions each visit)
Urine Creatinine Content
The urine creatinine content will be measured by a urinary creatinine colorimetric assay kit (Cayman Chemical).
sampled on day 6, 13, 20, and 27 (participant randomized to different interventions each visit)
Study Arms (4)
A: Whole Aronia Berry Powder
EXPERIMENTALB: Aronia Berry Extract
EXPERIMENTALC: Phospholipid-Polyphenol
EXPERIMENTALD: Low-Polyphenol Control
EXPERIMENTALInterventions
The food will be designed to be a berry-flavored applesauce. The food will include applesauce, sweeteners, citric acid, natural flavors and food colorants. Applesauce A will additionally contain whole aronia berry powder (Milne MicroDried, Nampa, ID).
The food will be designed to be a berry-flavored applesauce. The food will include applesauce, sweeteners, citric acid, natural flavors and food colorants. Applesauce B will additionally contain aronia berry extract (Artemis International, Fort Wayne, IN).
The food will be designed to be a berry-flavored applesauce. The food will include applesauce, sweeteners, citric acid, natural flavors and food colorants. Applesauce C will additionally contain PLP which will be prepared with commercially-available aronia juice concentrate (Greenwood Associates, Niles, IL) and soy lecithin (Whole Foods, Austin, TX).
The food will be designed to be a berry-flavored applesauce. The food will include applesauce, sweeteners, citric acid, natural flavors and food colorants. Applesauce D will not contain additional polyphenol-rich ingredients and is thus considered a low-polyphenol control.
Eligibility Criteria
You may qualify if:
- willing to consume low-anthocyanin diets during the last days of wash-in and wash-out periods
- willing to consume intervention foods during the sampling periods
- willing to provide 24-hour urine and fecal samples during the sampling periods.
You may not qualify if:
- people who do not consider themselves healthy
- anyone with a self-reported previous diagnosis of a gastrointestinal disease (e.g. inflammatory bowel disease, irritable bowel syndrome)
- undergoing current cancer treatment (i.e., chemotherapy, radiation therapy)
- are pregnant, lactating, or trying to become pregnant
- unwilling to consume study foods, or are allergic to sunflower, food colorants, berry ingredients, or any other component of the study foods.
- taking medication that contraindicates grapefruit juice consumption
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin
Madison, Wisconsin, 53706, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Bradley Bolling, PhD
University of Wisconsin, Madison
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2022
First Posted
August 5, 2022
Study Start
February 9, 2023
Primary Completion
March 28, 2023
Study Completion
March 28, 2023
Last Updated
March 31, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share